SCHEMBL1175741

SCHEMBL1175741

O=C1CC(C(=O)C(F)(F)F)C(=O)N1O

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
AADAT Q8N5Z0 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7851784 0.80 POLB (0.34)
SCHEMBL31235575 0.77 MT-CO2 (0.33) AADAT
SCHEMBL1408376 0.74 MAPT (0.35)
SCHEMBL1518987 0.72 ADAM17 (0.32)
SCHEMBL5881899 0.72 APEX1 (0.33) AADAT
SCHEMBL20756411 0.72
SCHEMBL8158871 0.71 AADAT (0.32) AADAT
SCHEMBL7767003 0.71 KDM4E (0.40)
SCHEMBL10344448 0.69 MAPK1 (0.39)
SCHEMBL7203585 0.68 BRD4 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150247863-A1 DERIVATIVES OF 1,2-DIHYDRO-7-HYDROXYQUINOLINES CONTAINING FUSED RINGS Life Technologies Corporation 2015-09-03 US disclosed
US-20140356873-A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings LIFE TECHNOLOGIES CORP (US) 2014-12-04 US disclosed
US-8846925-B2 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings Life Technologies Corporation (US) 2014-09-30 US disclosed
US-20120315661-A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings Life Technologies Corporation (US) 2012-12-13 US disclosed
US-8183375-B2 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings Life Technologies Corporation (US) 2012-05-22 US disclosed
US-20110027800-A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings Life Technologies Corporation (US) 2011-02-03 US disclosed
US-7816519-B2 longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands Life Technologies Corporation (US) 2010-10-19 US disclosed
US-20070093652-A1 longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands INVITROGEN CORPORATION (US) 2007-04-26 US disclosed
US-7169922-B2 Longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond INVITROGEN CORPORATION (US) 2007-01-30 US disclosed
US-20040147747-A1 Longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond MOLECULAR PROBES, INC. 2004-07-29 US disclosed
US-5190864-A Support-leash-enzyme conjugates, small amount of free enzyme releases large amount of bound enzyme NORTHEASTERN UNIVERSITY (US) 1993-03-02 US disclosed
US-4937188-A Enzyme activity amplification method for increasing assay sensitivity NORTHEASTERN UNIVERSITY (US) 1990-06-26 US disclosed
EP-0243797-A2 Method for amplifying enzyme activity, enzyme conjugates suitable therefor and their preparation NORTHEASTERN UNIVERSITY (US) 1987-11-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110027800-A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings CYP3A7, UGT1A7, UGT2B7 AADAT 3039/4885
US-20070093652-A1 longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands CYP3A4, CYP3A5, UGT1A4 AADAT 2287/4885
US-20150247863-A1 DERIVATIVES OF 1,2-DIHYDRO-7-HYDROXYQUINOLINES CONTAINING FUSED RINGS CYP3A7, UGT1A7, UGT2B7 AADAT 3039/4885
US-20140356873-A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings CYP3A7, UGT1A7, UGT2B7 AADAT 3039/4885
US-20040147747-A1 Longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond CYP3A4, CYP3A5, UGT1A4 AADAT 1868/4885
US-20120315661-A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings CYP3A7, UGT1A7, UGT2B7 AADAT 3039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.